[feed] Atom [feed] RSS 1.0 [feed] RSS 2.0

Paul, D. and Bargale, A.B. and Rapole, S. and Shetty, P.K. and Santra, M.K. (2018) Protein Phosphatase 1Regulatory Subunit SDS22 Inhibits Breast Cancer Cell Tumorigenesis by Functioningas a Negative Regulator of the AKT Signaling Pathway. Neoplasia., 21 (1). pp. 30-40.

[img] Text
45-1.Dr. Manas S. (Neoplasia) open access.pdf
Restricted to Repository staff only

Download (1905Kb) | Request a copy


Protein phosphatases play a crucial role in cell cycle progression, cell survival, cellular signaling, and genomic integrity. The protein phosphatase 1 (PP1) regulatory subunit SDS22 plays a significant role in cell cycle progression. A recent study showed that SDS22 plays a vital role in epithelial integrity and tumor suppression in Drosophila. However, its tumor suppressive activity remains obscure in the mammalian system. Here, for the first time, we show that SDS22 inhibits the growth of breast cancer cells through induction of apoptosis. SDS22 negatively regulates the AKT kinase signaling pathway through PP1. SDS22 associates predominantly with AKT and dephosphorylates the phospho Thr308 and phospho Ser473 through PP1 and hence abrogates the cell migration, invasion, and tumor growth. Thus, our study deciphers the long-standing question of how PP1 negatively regulates the AKT signaling pathway. Further, we observed a significant converse correlation in the expression levels of SDS22 and phospho form of AKT with reduced levels of SDS22 in the higher grades of cancer. Overall, our results suggest that SDS22 could be a putative tumor suppressor and replenishment of SDS22 would be an important strategy to restrict the tumor progression

Item Type: Article
Depositing User: Mr. Rameshwar Nema
Date Deposited: 13 Feb 2020 07:24
Last Modified: 09 Dec 2021 11:37
URI: http://nccs.sciencecentral.in/id/eprint/635

Actions (login required)

View Item View Item